O -GlcNAcylation of epidermal growth factor receptor and glucose transporter 1 prevents their intrinsic down regulation in breast cancer cells
Biochemistry and Cell Biology · 2025
DOI: 10.1139/bcb-2025-0055 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemistry and Cell Biology, 2025. Verfasst von G Pauline Padilla-Meier und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada. Hauptthemen laut MEDLINE: Breast Neoplasms, ErbB Receptors, Glucose Transporter Type 1, Down-Regulation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Canadian Breast Cancer Foundation, Natural Sciences and Engineering Research Council, Institute of Gender and Health.
Abstract (Originalsprache)
The hexosamine biosynthetic pathway (HBP) is upregulated in many cancer cell types leading to upregulation of post-translational modification of proteins by β- N-acetylglucosamine ( O-GlcNAc), the product of HBP. However, our knowledge of the identity of proteins that undergo O-GlcNAcylation in cancer cells and consequently their roles is very limited. We investigated the O-GlcNAcylation of epidermal growth factor receptor (EGFR) and glucose transporter 1 (GLUT1) in T47D and MDA-MB-231 breast cancer cell models. We examined the effect of the loss of putative O-GlcNAcylation sites in EGFR and GLUT1 on cell-signaling pathways and their functional consequences on cell cycle progression and cell metabolism using fluorescence-activated cell sorting analysis and in vitro assays. EGFR and GLUT1 undergo O-GlcNAcylation in T47D and MDA-MB-231 breast cancer cells, which enhances their functions and prevents their intrinsic downregulation. This appears to involve an interplay between phosphorylation, O-GlcNAcylation, and ubiquitination in both proteins. Importantly, perturbing the putative O-GlcNAcylation sites in both proteins adversely affected their stability, functions, and metabolic status of breast cancer cells, including glucose uptake and lactate production. In conclusion, the reprogrammed metabolism in cancer cells extends beyond energy and macromolecule requirements and contributes to cell-signaling events that support the stability and function of cancer promoting proteins.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada.
- Department of Physiology & Pathophysiology, Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada.
ORCID-Profile: Suresh Mishra
Förderung
- Canadian Breast Cancer Foundation
- Natural Sciences and Engineering Research Council
- Institute of Gender and Health
Zitieren
APA
Padilla-Meier, G., Bhatia, Y., & Mishra, S. (2025). O -GlcNAcylation of epidermal growth factor receptor and glucose transporter 1 prevents their intrinsic down regulation in breast cancer cells. Biochemistry and Cell Biology. https://doi.org/10.1139/bcb-2025-0055
Vancouver
Padilla-Meier G, Bhatia Y, Mishra S. O -GlcNAcylation of epidermal growth factor receptor and glucose transporter 1 prevents their intrinsic down regulation in breast cancer cells. Biochemistry and Cell Biology. 2025. doi:10.1139/bcb-2025-0055
BibTeX
@article{PadillaMeier2025,
author = {Padilla-Meier, G Pauline and Bhatia, Yeshika and Mishra, Suresh},
title = {O -GlcNAcylation of epidermal growth factor receptor and glucose transporter 1 prevents their intrinsic down regulation in breast cancer cells},
journal = {Biochemistry and Cell Biology},
year = {2025},
doi = {10.1139/bcb-2025-0055}
}
EUVIMED